Global Nuclear Medicine Market 2016-2020

This market research report presents a detailed segmentation of the global nuclear medicine market by product (nuclear medicine equipment market and radiopharmaceutical), by application (oncology, cardiology, and neurology), by end user (diagnostic centers, hospitals, and research centers), and by geography (the Americas, APAC, and EMEA). Key vendors in the market include Cardinal Health, Digirad, GE Healthcare, Lantheus Medical Imaging, and Philips Healthcare.

Overview of the global nuclear medicine market

Technavio’s market research analysts expect the global nuclear medicine market to grow at a CAGR of more than 8% during the forecast period. The high demand for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging is one of the primary drivers for this market.  The SPECT, PET, and CT technologies and hybrid technologies play a major role in the early diagnosis and easy comprehension of various types of cancer, CVDs, and orthopedic disorders. These technologies are finding extensive usage in interventional cardiology and angioplasty procedures, where the patients are tracked with nuclear medicine in the imaging procedure. Increased awareness about SPECT/CT and PET/CT medical imaging will drive the prospects for technological progress in this market over the next four years.

As per this market research analysis, several nuclear medicine and nuclear imaging companies are forming strategic partnerships to resolve the radiopharmaceutical concerns in medical imaging and to increase their market reach. Such alliances will increase the production of radiopharmaceuticals at lower costs, thereby, boosting the growth of this market. For instance, with the strategic partnership of Piramal Imaging and ISOLOGIC Innovative Radiopharmaceuticals, ISOLOGIC received exclusive rights to manufacture, market and distribute Neuraceq (radiopharmaceutical) for PET imaging in Canada.

Segmentation by product and analysis of the nuclear medicine market

• Nuclear medicine equipment market
• Radiopharmaceutical   

The radiopharmaceuticals segment accounted for the largest market share during 2015 and is expected to be the fastest-growing market segment by 2020. Much of this segment’s growth can be attributed to the growing use of radioactive pharmaceutical drugs in nuclear medicine as nuclear imaging agents. The augmented usage of various medical radioisotopes such as iodine-124, copper-64, and FDG in molecular studies will boost the growth of this market during the forecast period.

Geographical segmentation and analysis of the nuclear medicine market

• Americas
• APAC
• EMEA

The Americas dominated the nuclear medicine market in 2015 and occupied around 60% of the overall market revenue. Factors such as increasing aging population, advances in technology, and the presence of favorable reimbursement policies are contributing to the market’s growth in this region. Also, the increased usage of SPECT/CT and PET/CT imaging techniques will accelerate this region’s growth during the forecast period.

Competitive landscape and key vendors

This market is highly competitive owing to the presence of many vendors who compete on the basis of product development, distribution network, pricing and performance, advertising and promotion campaigns, and brand positioning. The level of competition in the market is expected to intensify in the coming years as the key vendors are developing highly advanced hybrid nuclear imaging equipment. At present, many manufacturers are also partnering with healthcare institutes to extend their geographical presence in the market.

Key vendors in this market are -

• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare

Other prominent vendors in the market are ABT Molecular Imaging, Advanced Accelerator Applications, AGFA Healthcare, Algeta, Astellas Pharma, Bayer, Bracco Imaging, Brain Biosciences, Capintec, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular Imaging, ISOLOGIC Innovative Radiopharmaceuticals, Jubilant DraxImage, Mallinckrodt, Mediso Medical Imaging System, Mirada Medical, Navidea Biopharmaceuticals, Nordion, Piramal Imaging, Positron Pharmaceutical Company, RadioMedix, SHINE Medical Technologies, Sophie Biosciences, Toshiba Medical Systems, Triad Isotopes, and Voxel.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global nuclear medicine market?
• What are the key market trends impacting the growth of the global nuclear medicine market?
• What are the challenges to market growth?
• Who are the key vendors in the global nuclear medicine market?
• What are the market opportunities and threats faced by the vendors in the global nuclear medicine market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global nuclear medicine market?

Technavio also offers customization on reports based on specific client requirement